Kopran Limited (BOM:524280)

Market Cap	6.48B -30.0%
Revenue (ttm)	6.20B -3.7%
Net Income	165.43M -65.2%
EPS	3.42 -65.3%
Shares Out	48.29M
PE Ratio	39.31
Forward PE	n/a
Dividend	3.00 (2.20%)
Ex-Dividend Date	Sep 4, 2025

Volume	6,186
Average Volume	12,386
Open	132.05
Previous Close	139.40
Day's Range	132.05 - 139.00
52-Week Range	119.60 - 214.65
Beta	0.31
RSI	47.59
Earnings Date	Jan 22, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In fiscal year 2025, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.